BD Receives FDA Emergency Use Authorization for COVID-19, Influenza A/B, RSV Combination Test

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received Emergency Use...

Related Keywords

Troy Kirkpatrick ,Francesca Demartino ,Linkedin ,Human Services ,Viral Panel ,Biomedical Advanced Research ,Drug Administration ,Office Of The Administration For Strategic Preparedness ,Development Authority ,Department Of Health ,Bd Respiratory Viral Panel ,Single Test ,Molecular Diagnostic System Identifies ,Emergency Use Authorization ,Respiratory Syncytial Virus ,Molecular Diagnostic System ,Nikos Pavlidis ,Molecular Diagnostics ,Respiratory Viral Panel ,Strategic Preparedness ,Federal Food ,Cosmetic Act ,Bd Becton ,Ickinson And Company ,